S1034 Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices

Name of the Procedure:

Artificial Pancreas Device System (S1034)

Commonly referred to as:

• Artificial Pancreas
• Closed-Loop Insulin Delivery System
• Low Glucose Suspend (LGS) Feature

Summary

An artificial pancreas device system is an advanced medical technology designed to help people with diabetes manage their blood sugar levels. It includes a continuous glucose monitor (CGM), an insulin pump, and a computer algorithm that communicates with both devices to automatically adjust insulin delivery based on real-time glucose readings.

Purpose

Medical Conditions:

• Type 1 Diabetes
• Insulin-dependent Type 2 Diabetes

Goals:

• Maintain optimal blood glucose levels.
• Minimize the risk of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar).
• Improve overall diabetes management and quality of life.

Indications

Symptoms/Conditions:

• Frequent episodes of hypoglycemia.
• Difficulty maintaining stable blood glucose levels.
• Poor HbA1c control despite conventional treatment.

Patient Criteria:

• Diagnosed with insulin-dependent diabetes.
• Previously tried multiple daily insulin injections or standard insulin pump therapy without sufficient control.

Preparation

Pre-Procedure Instructions:

• Keep a log of recent glucose readings.
• Continue usual diabetes medications unless instructed otherwise by a healthcare provider.
• Attend training sessions on how to use the CGM and insulin pump.

Diagnostic Tests/Assessments:

• Comprehensive metabolic panel.
• Glycated hemoglobin (HbA1c) test.
• Assessment of current diabetes management practices.

Procedure Description

1. Continuous Glucose Monitor (CGM): A sensor is inserted under the skin to continuously measure glucose levels in the interstitial fluid.
2. Insulin Pump: A small device worn on the body that delivers insulin through a catheter placed under the skin.
3. Computer Algorithm: Software calculates insulin needs based on CGM data and communicates with the insulin pump to adjust delivery in real-time.
4. Blood Glucose Device: Used initially to calibrate the CGM and for occasional additional glucose checks.

Technology Used:

• CGM sensors.
• Insulin pump.
• Computer algorithm with a control device (smartphone or dedicated monitor).

Anesthesia/Sedation:

• Typically not required.

Duration

• Initial setup and training may take several hours.
• Ongoing use is continuous, with periodic maintenance and calibration.

Setting

• Outpatient diabetes clinic or specialized medical facility.

Personnel

• Endocrinologist or diabetologist.
• Certified diabetes educator.
• Registered nurse specialized in diabetes care.
• Technical support staff for device setup.

Risks and Complications

Common Risks:

• Skin irritation or infection at sensor/pump sites.
• False or inaccurate glucose readings.
• Device malfunction.

Rare Complications:

• Severe hypoglycemia or hyperglycemia if the system fails.
• Allergic reactions to adhesives or materials.

Management:

• Regular monitoring and troubleshooting.
• Education on manual insulin administration in case of device failure.

Benefits

• Improved blood glucose control.
• Reduced frequency and severity of hypoglycemia.
• Enhanced quality of life and ease of diabetes management.
• Benefits can be realized within days to weeks of initiating therapy.

Recovery

Post-Procedure Care:

• Regular device maintenance, such as sensor replacements and pump site changes.
• Continuous monitoring of blood glucose levels.

Recovery Time:

• No downtime required; patients can resume normal activities immediately.
• Periodic follow-up appointments for assessment and device calibration.

Alternatives

Other Treatment Options:

• Multiple daily insulin injections.
• Standard insulin pump without CGM integration.

Pros and Cons:

• Daily Injections: Less costly but more manual management.
• Standard Insulin Pump: Offers continuous delivery but requires manual blood glucose monitoring and adjustments.

Patient Experience

During the Procedure:

• Initial discomfort from sensor and catheter insertions.
• Learning curve for device operation.

After the Procedure:

• Potential skin irritation.
• Continuous monitoring offers peace of mind.
• Adjustments in insulin delivery can improve overall comfort.
• Education on dealing with alarms and troubleshooting is crucial for successful use.

Pain Management and Comfort Measures:

• Local anesthetic creams for site insertions.
• Ongoing support from healthcare providers to address concerns and optimize device settings.